BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35332289)

  • 1. Baseline retinal vascular bed area on ultra-wide field fluorescein angiography correlates with the anatomical outcome of diabetic macular oedema to ranibizumab therapy: two-year analysis of the DAVE Study.
    Fan W; Uji A; Wykoff CC; Brown DM; van Hemert J; Falavarjani KG; Wang K; Sadda SR; Ip M
    Eye (Lond); 2023 Mar; 37(4):678-683. PubMed ID: 35332289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SEVERITY OF DIABETIC MACULAR EDEMA CORRELATES WITH RETINAL VASCULAR BED AREA ON ULTRA-WIDE FIELD FLUORESCEIN ANGIOGRAPHY: DAVE Study.
    Fan W; Uji A; Wang K; Falavarjani KG; Wykoff CC; Brown DM; Van Hemert J; Sagong M; Sadda SR; Ip M
    Retina; 2020 Jun; 40(6):1029-1037. PubMed ID: 31356494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of Nonperfusion Area on Ultra-widefield Fluorescein Angiography in Eyes With Diabetic Macular Edema: DAVE Study.
    Fan W; Wang K; Ghasemi Falavarjani K; Sagong M; Uji A; Ip M; Wykoff CC; Brown DM; van Hemert J; Sadda SR
    Am J Ophthalmol; 2017 Aug; 180():110-116. PubMed ID: 28579062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal vascular bed area on ultra-wide field fluorescein angiography indicates the severity of diabetic retinopathy.
    Fan W; Uji A; Nittala M; Wykoff CC; Brown D; Fleming A; Robertson G; van Hemert J; Sadda S; Ip MS
    Br J Ophthalmol; 2022 Aug; 106(8):1126-1131. PubMed ID: 33827861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography.
    Fan W; Nittala MG; Fleming A; Robertson G; Uji A; Wykoff CC; Brown DM; van Hemert J; Ip M; Wang K; Falavarjani KG; Singer M; Sagong M; Sadda SR
    Am J Ophthalmol; 2020 Jan; 209():99-106. PubMed ID: 31472160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NEW BIOMARKER QUANTIFYING THE EFFECT OF ANTI-VEGF THERAPY IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY ON ULTRAWIDE FIELD FLUORESCEIN ANGIOGRAPHY: RECOVERY Study.
    Fan W; Nittala MG; Wykoff CC; Brown DM; Uji A; Hemert JV; Fleming A; Robertson G; Sadda SR; Ip M
    Retina; 2022 Mar; 42(3):426-433. PubMed ID: 34803132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of Regions of Nonperfusion on Ultra-widefield Fluorescein Angiography in Patients with Diabetic Macular Edema.
    Fang M; Fan W; Shi Y; Ip MS; Wykoff CC; Wang K; Falavarjani KG; Brown DM; van Hemert J; Sadda SR
    Am J Ophthalmol; 2019 Oct; 206():74-81. PubMed ID: 30959003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor.
    Couturier A; Rey PA; Erginay A; Lavia C; Bonnin S; Dupas B; Gaudric A; Tadayoni R
    Ophthalmology; 2019 Dec; 126(12):1685-1694. PubMed ID: 31383483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precise Measurement of Retinal Vascular Bed Area and Density on Ultra-wide Fluorescein Angiography in Normal Subjects.
    Fan W; Uji A; Borrelli E; Singer M; Sagong M; van Hemert J; Sadda SR
    Am J Ophthalmol; 2018 Apr; 188():155-163. PubMed ID: 29428456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of Nonperfusion and Neovascularization on Ultrawide-Field Fluorescein Angiography in Proliferative Diabetic Retinopathy (RECOVERY Study): Report 1.
    Fan W; Nittala MG; Velaga SB; Hirano T; Wykoff CC; Ip M; Lampen SIR; van Hemert J; Fleming A; Verhoek M; Sadda SR
    Am J Ophthalmol; 2019 Oct; 206():154-160. PubMed ID: 31078541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of diabetic macular oedema using ultra-widefield angiography and implications for response to anti-VEGF therapy.
    Xue K; Yang E; Chong NV
    Br J Ophthalmol; 2017 May; 101(5):559-563. PubMed ID: 27531355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RETINAL VASCULAR BED AREA IN EYES WITH RETINAL VEIN OCCLUSION ON ULTRA-WIDEFIELD FLUORESCEIN ANGIOGRAPHY: WAVE Study.
    Fan W; Fleming A; Hemert JV; Wykoff CC; Brown DM; Robertson G; Wang K; Falavarjani KG; Sadda SR; Ip M
    Retina; 2022 Oct; 42(10):1883-1888. PubMed ID: 35976232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
    Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
    Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISE.
    Reddy RK; Pieramici DJ; Gune S; Ghanekar A; Lu N; Quezada-Ruiz C; Baumal CR
    Ophthalmology; 2018 Oct; 125(10):1568-1574. PubMed ID: 29752001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE Trial.
    Brown DM; Ou WC; Wong TP; Kim RY; Croft DE; Wykoff CC;
    Ophthalmology; 2018 May; 125(5):683-690. PubMed ID: 29336896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.
    Karst SG; Lammer J; Mitsch C; Schober M; Mehta J; Scholda C; Kundi M; Kriechbaum K; Schmidt-Erfurth U
    Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):49-58. PubMed ID: 29080915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema.
    Wong Y; Steel DHW; Habib MS; Stubbing-Moore A; Bajwa D; Avery PJ;
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):733-742. PubMed ID: 27957600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of baseline diabetic retinopathy status on initial anatomical response of intravitreal ranibizumab therapy for diabetic macular oedema.
    Nicholson L; Patrao NV; Ramu J; Vazquez-Alfageme C; Muwas M; Rajendram R; Hykin PG; Sivaprasad S
    Eye (Lond); 2017 Sep; 31(9):1358-1364. PubMed ID: 28452992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMPACT OF LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON PREEXISTING MICROSTRUCTURAL ALTERATIONS IN DIABETIC MACULAR EDEMA.
    Wirth MA; Wons J; Freiberg FJ; Becker MD; Michels S
    Retina; 2018 Sep; 38(9):1824-1829. PubMed ID: 28767550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Region-specific ischemia, neovascularization and macular oedema in treatment-naïve proliferative diabetic retinopathy.
    Lange J; Hadziahmetovic M; Zhang J; Li W
    Clin Exp Ophthalmol; 2018 Sep; 46(7):757-766. PubMed ID: 29412501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.